These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 33438587)
1. Regenerative medicine as a novel strategy for AMD treatment: a review. Tavakoli Z; Yazdian F; Tabandeh F; Sheikhpour M Biomed Phys Eng Express; 2019 Nov; 6(1):012001. PubMed ID: 33438587 [TBL] [Abstract][Full Text] [Related]
2. Stem cell based therapies for age-related macular degeneration: The promises and the challenges. Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213 [TBL] [Abstract][Full Text] [Related]
3. Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD). Surendran H; Rathod RJ; Pal R Methods Mol Biol; 2019; 2045():283-298. PubMed ID: 29896658 [TBL] [Abstract][Full Text] [Related]
13. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy]. Tamaki Y Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564 [TBL] [Abstract][Full Text] [Related]
14. Cell-Based Therapies for Age-Related Macular Degeneration. Khateb S; Jha S; Bharti K; Banin E Adv Exp Med Biol; 2021; 1256():265-293. PubMed ID: 33848006 [TBL] [Abstract][Full Text] [Related]
15. Langmuir-Schaefer film deposition onto honeycomb porous films for retinal tissue engineering. Calejo MT; Ilmarinen T; Vuorimaa-Laukkanen E; Talvitie E; Hakola HM; Skottman H; Kellomäki M Acta Biomater; 2017 May; 54():138-149. PubMed ID: 28223209 [TBL] [Abstract][Full Text] [Related]
16. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. da Cruz L; Fynes K; Georgiadis O; Kerby J; Luo YH; Ahmado A; Vernon A; Daniels JT; Nommiste B; Hasan SM; Gooljar SB; Carr AF; Vugler A; Ramsden CM; Bictash M; Fenster M; Steer J; Harbinson T; Wilbrey A; Tufail A; Feng G; Whitlock M; Robson AG; Holder GE; Sagoo MS; Loudon PT; Whiting P; Coffey PJ Nat Biotechnol; 2018 Apr; 36(4):328-337. PubMed ID: 29553577 [TBL] [Abstract][Full Text] [Related]
17. Stem cell-derived retinal pigment epithelium transplantation for treatment of retinal disease. Nommiste B; Fynes K; Tovell VE; Ramsden C; da Cruz L; Coffey P Prog Brain Res; 2017; 231():225-244. PubMed ID: 28554398 [TBL] [Abstract][Full Text] [Related]
18. Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration. Dehghan S; Mirshahi R; Shoae-Hassani A; Naseripour M Stem Cell Res Ther; 2022 May; 13(1):217. PubMed ID: 35619143 [TBL] [Abstract][Full Text] [Related]
19. Surgical Transplantation of Human RPE Stem Cell-Derived RPE Monolayers into Non-Human Primates with Immunosuppression. Liu Z; Parikh BH; Tan QSW; Wong DSL; Ong KH; Yu W; Seah I; Holder GE; Hunziker W; Tan GSW; Barathi VA; Lingam G; Stanzel BV; Blenkinsop TA; Su X Stem Cell Reports; 2021 Feb; 16(2):237-251. PubMed ID: 33450191 [TBL] [Abstract][Full Text] [Related]
20. RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells. Inana G; Murat C; An W; Yao X; Harris IR; Cao J J Transl Med; 2018 Mar; 16(1):63. PubMed ID: 29534722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]